Blood ionized extracellular calcium is closely regulated. To accomplish thi
s, a hormone-like receptor that is responsive to extracellular ionized calc
ium regulates both the secretion of parathyroid hormone and the excretion o
f urinary calcium (as well as other cellular processes). Several hereditary
disorders have mutations that cause either loss or gain of function of the
calcium-sensing receptor, and alterations of the calcium-sensing receptor
may play a role in both primary and secondary hyperparathyroidism. Calcimim
etics are agents that act to make the calcium-sensing receptor more sensiti
ve to extracellular ionized calcium; thereby they suppress the secretion of
parathyroid hormone. Early trials in animal models of secondary hyperparat
hyroidism and in patients with primary hyperparathyroidism or with uremic s
econdary hyperparathyroidism have shown that the first generation calcimime
tic, R-568, effectively lowers parathyroid hormone levels and is well toler
ated. Curr Opin Nephrol Hypertens 9:123-132. (C) 2000 Lippincott Williams &
Wilkins.